Cargando…
Growing evidence of the safety of JAK inhibitors in patients with rheumatoid arthritis
To facitinib and baricitinib are two of the currently available Janus kinase (JAK) inhibitors for the treatment of patients with RA. Randomized controlled trials have shown that these JAK inhibitors are as efficacious as biological DMARDs. Safety profiles of these JAK inhibitors in randomized contro...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390880/ https://www.ncbi.nlm.nih.gov/pubmed/30806708 http://dx.doi.org/10.1093/rheumatology/key287 |